| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500396 | Farmacia Hospitalaria | 2008 | 8 Pages |
Abstract
the implementation of an improvement programme for the quality of pharmacotherapy with erythropoiesis-stimulating agents in patients with haemodialysis significantly increases the proportion of patients with haemoglobin values within the recommended ranges of effectiveness and safety.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
T. de Diego Santos, M. Climente MartÃ, E.V. Albert Balaguer, N.V. Jiménez Torres,